MORRISON C. ENGLAND, JR., District Judge.
1. Plaintiff E*Healthline, Inc. ("EHL") previously granted a two-week extension to Defendant Pharmaniaga Berhad ("Pharmaniaga") to file a responsive pleading to the Complaint in this case.
2. On July 13, 2018, Pharmaniaga filed its Motion to Dismiss the Complaint ("Motion to Dismiss"), setting it for hearing on August 23, 2018 (Dkt. 20).
3. On July 19, 2018, the Court vacated the hearing pursuant to Local Rule 230(g) (Dkt. 27) but stated that opposition and reply due dates would remain set in accordance with the original motion hearing date.
3. EHL and Pharmaniaga believe that it would be appropriate to permit additional time to respond to the Motion to Dismiss.
4. The parties therefore stipulate and request that the Court order that EHL's opposition to the Motion to Dismiss shall be due on August 23, 2018, and Pharmaniaga's reply shall be due on September 6, 2018.
5. If the Court elects to reinstate oral argument, the parties respectfully request that the hearing be scheduled on or after September 20, 2018, so that the briefing deadlines will comply with Local Rule 230(c) and (d).
Pursuant to the stipulation of the parties and good cause appearing, the Court orders the following briefing schedule:
Pharmaniaga's Motion to Dismiss shall remain submitted, with EHL's opposition due on August 23, 2018, and Pharmaniaga's reply due on September 6, 2018.